{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:28:37Z","timestamp":1793762917345,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Social Science & Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.socscimed.2025.118521","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:11:49Z","timestamp":1756307509000},"page":"118521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Temporal and spatial patterns of xylazine and medetomidine detected in the DEA's National Forensic Laboratory Information System (NFLIS) reports"],"prefix":"10.1016","volume":"384","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-495X","authenticated-orcid":false,"given":"David T.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhanee","family":"Mitragotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.socscimed.2025.118521_bib2","article-title":"Drug supply measures and drug overdose mortality in the era of fentanyl and stimulants","volume":"9","author":"Cano","year":"2023","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"10.1016\/j.socscimed.2025.118521_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50630","article-title":"Xylazine in overdose deaths and forensic drug reports in US States, 2019-2022","volume":"7","author":"Cano","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.socscimed.2025.118521_bib4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine adulteration of the heroin-fentanyl drug supply : a narrative review","volume":"176","author":"D'Orazio","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.socscimed.2025.118521_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.socscimed.2025.118521_bib6","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1097\/MS9.0000000000002190","article-title":"Xylazine in illicit drug mixtures: a growing threat and overlooked danger","volume":"86","author":"Habib","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.socscimed.2025.118521_bib7","article-title":"Medetomidine rapidly proliferating across USA \u2014 implicated in recreational opioid drug supply & causing overdose outbreaks","author":"Krotulski","year":"2024","journal-title":"Center for Forensic Science Research and Education"},{"key":"10.1016\/j.socscimed.2025.118521_bib8","article-title":"Medetomidine rapidly proliferating across USA \u2014 implicated in recreational opioid drug supply & causing overdose outbreaks","author":"Krotulski","year":"2024","journal-title":"Center for Forensic Science Research and Education"},{"key":"10.1016\/j.socscimed.2025.118521_bib10","article-title":"Outbreak of overdoses involving medetomidine mixed with opioids \u2014 chicago, Illinois","author":"Nham","year":"2024","journal-title":"May 2024. Chicago Department of Public Health"},{"issue":"17","key":"10.1016\/j.socscimed.2025.118521_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jama.2024.15992","article-title":"Medetomidine infiltrates the US illicit opioid market","volume":"332","author":"Palamar","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.socscimed.2025.118521_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/1556-4029.15269","article-title":"Understanding research methods, limitations, and applications of drug data collected by the National Forensic Laboratory Information System (NFLIS-Drug)","volume":"68","author":"Pitts","year":"2023","journal-title":"J. Forensic Sci."},{"issue":"11","key":"10.1016\/j.socscimed.2025.118521_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.2024.27550","article-title":"UV stabilizer BTMPS in the illicit fentanyl supply in 9 US locations","volume":"333","author":"Shover","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.socscimed.2025.118521_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23033","article-title":"Estimating weekly national opioid overdose deaths in near real time using multiple proxy data sources","volume":"5","author":"Sumner","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.socscimed.2025.118521_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112553","article-title":"Characterization of xylazine-related overdose deaths in Maryland (2020-2023)","volume":"268","author":"Wang","year":"2025","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.socscimed.2025.118521_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-023-00867-x","article-title":"Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review","volume":"20","author":"Zhu","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.socscimed.2025.118521_bib22","article-title":"Fentanyl-xylazine overdose deaths in the USA, 2018-2023","author":"Zhu","year":"2025","journal-title":"Inj. Prev."},{"key":"10.1016\/j.socscimed.2025.118521_bib23","article-title":"Responding to medetomidine: clinical and public health needs","volume":"44","author":"Zhu","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"10416","key":"10.1016\/j.socscimed.2025.118521_bib24","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(23)01686-0","article-title":"The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions","volume":"402","author":"Zhu","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.socscimed.2025.118521_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2025.2307","article-title":"The rapid spread of a novel adulterant in the US illicit drug Supply-BTMPS","author":"Zhu","year":"2025","journal-title":"JAMA Intern. Med."}],"container-title":["Social Science & Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625008524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0277953625008524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:27:58Z","timestamp":1780115278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0277953625008524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"alternative-id":["S0277953625008524"],"URL":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118521","relation":{},"ISSN":["0277-9536"],"issn-type":[{"value":"0277-9536","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal and spatial patterns of xylazine and medetomidine detected in the DEA's National Forensic Laboratory Information System (NFLIS) reports","name":"articletitle","label":"Article Title"},{"value":"Social Science & Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.socscimed.2025.118521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118521"}}